David D. Shepard, MD joined the cancer care team of Northwest Georgia Oncology Centers in June 2011 after completing his Fellowship in Medical Oncology and Hematology at the University of Michigan.

Dr. Shepard is actively involved in cancer research and clinical trials to find a cancer cure and provide his patients with the most advanced cancer treatment available in Georgia.

Dr. Shepard delivers patient-centered cancer care at NGOC's Carrollton Cancer Center.
Georgia Cancer Doctor - David Shepard, MD.
OFFICE ADDRESS NORTHWEST GEORGIA ONCOLOGY CENTERS, P.C.
CARROLLTON CENTER
157 Clinic Ave Suite 101
Carrollton, GA 30117
Phone: Phone: 770-333-2220 Fax: 678-581-7180
PERSONAL DATA Birthplace: Evanston, IL
UNDERGRADUATE EDUCATION BS, Major in Biology, May 2001
Morehouse College
Atlanta, Georgia
MEDICAL EDUCATION MD, June 2005
Indiana University, School of Medicine
Indianapolis, IN
POSTDOCTORAL TRAINING INTERNSHIP and RESIDENCY
Straight Internal Medicine
St. Vincent Hospital
Indianapolis, IN
July 2005 - June 2008

FELLOWSHIP
Hematology and Medical Oncology
University of Michigan
Ann Arbor, Michigan
July 2008 - June 2011
BOARD CERTIFICATION American Board of Internal Medicine, Internal Medicine, 2008,
MEDICAL LICENSURE May 2011, Physician, Georgia
PROFESSIONAL SOCIETIES American Society of Clinical Oncology, 2009 - Present
American Society of Hematology, 2009 - Present
National Medical Association, 2005 - Present
COMMITTEE, ORGANIZATIONAL & VOLUNTEER SERVICE

Physician Mentor, Student National Medical Association, Mentor to first and second year medical students, 2008 to 2011

Co-founder & Director, Male Rites of Passage Program, Served as one of seven mentors for underprivileged youth in program that focused on instilling self-respect, confidence, and love for learning, 2004 -2007

Blackburn Men?s Health Fair, Indianapolis, Conducted blood pressure screenings and focused physical exams on male patients in an underserved community, Indiana, 2004

PUBLICATIONS ABSTRACTS:
Shepard D, Estes J, Griffith K, Kaminski M. Duration of Remission using I-131 tositumomab in patients with B-cell lymphoma relapsing after autologous stem cell transplant. ASCO Annual Meeting, abstract 2010.

Shepard D, Khort H, Rosenblat T, et al. Arsenic trioxide followed by autologous stem cell transplant for patients with relapsed APL. ASCO Annual Meeting Abstracts 2011 Abstract #6619

Bixby D, Shepard D, , Rogers K, Avram AM, Kaminski MS. I-131 Tositumomab (Bexxar) can be safely given to lymphoma patients who are intolerant of rituximab. ASCO Annual Meeting Abstracts 2011

PUBLICATIONS:
Shepard D. Increasing Awareness ? The Clinician Educator Track in Academic Medicine. The Hematologist, 2010, 7:3.

David W. Brown, MSPH, MSc, David Shepard, Wayne H. Giles, MD, MSc, Kurt J. Greenlund, PhD, and Janet B. Croft, PhD. (2005, Oct). Racial Differences in the Use of Aspirin: An Important Tool for Preventing Heart Disease and Stroke. Journal of Ethinicity and Disease, 15(4), 620 - 626.

Burwick N, Shepard D. ASH Makes a Positive Imprint on New Orleans High School Students. The Hematologist, 2010, 7:1.
MAJOR RESEARCH INTERESTS Clinical Trials (Oncology & Hematology)
For a listing of the Active Clinical Trials that NGOC participates in, click here
Use your browser's "back" button to return to this physician's page

WILLIAM S. GIBBONS CANCER RESEARCH INSTITUTE | SEARCH-THE-SITE

back to Physicians List